NovaBay Pharmaceuticals (NBY) Q3 2023 Earnings

9NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-3.5
-2.46
-1.41
-0.37

Details

Expected EPS
-0.4
Actual EPS
-0.37
Surprise EPS
0.03
Surprise Percent
+7.5%

Description

NovaBay Pharmaceuticals (NBY) has reported earnings of -0.37 per share for Q3 2023.

0 Comments

Share your thoughts